2 documents found, page 1 of 1
Comorbidities, timing of treatments, and chemotherapy use influence outcomes in...
Minicozzi, P; Vicentini, M; Innos, K; Castro, C; Guevara, M; Stracci, F; Carmona-Garcia, M; Rodriguez-Barranco, M; Vanschoenbeek, K; Rapiti, EIntroduction For stage III colon cancer (CC), surgery followed by chemotherapy is the main curative approach, although optimum times between diagnosis and surgery, and surgery and chemotherapy, have not been established. Materials and methods We analysed a population-based sample of 1912 stage III CC cases diagnosed in eight European countries in 2009–2013 aiming to estimate: (i) odds of receiving postoperative...
Comorbidities, age and period of diagnosis influence treatment and outcomes in ...
Minicozzi, P; Van Eycken, L; Molinie, F; Innos, K; Guevara, M; Marcos-Gragera, R; Castro, C; Rapiti, E; Katalinic, A; Torrella, A; Žagar, TSurvival for breast cancer (BC) is lower in eastern than northern/central Europe, and in older than younger women. We analysed how comorbidities at diagnosis affected whether selected standard treatments (STs) were given, across Europe and over time, also assessing consequences for survival/relapse. We analysed 7581 stage I/IIA cases diagnosed in 9 European countries in 2009–2013, and 4 STs: surgery; breast-con...